Copper Cu 64 TP3805

DRUG4 trials

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions

Bladder Urothelial CarcinomaBreast CarcinomaProstate AdenocarcinomaProstate CancerStage IIB Prostate CancerStage III Prostate CancerStage IV Prostate CancerUrothelial Carcinoma

Early Phase 1

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

CompletedNCT03039413

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityBladder Urothelial Carcinoma, Urothelial Carcinoma

Start: 2016-09-28End: 2024-07-19Updated: 2025-08-22

Phase 1

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

CompletedNCT02603965

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityProstate Adenocarcinoma, Stage IIB Prostate Cancer, Stage III Prostate Cancer +1

Start: 2013-08-31End: 2014-09-30Updated: 2025-05-02

Unknown Phase

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

TerminatedNCT02810873

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityBreast Carcinoma

Start: 2008-09-30End: 2012-07-31Updated: 2025-05-04

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

CompletedNCT02989623

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityProstate Cancer

Start: 2015-09-01End: 2019-04-25Updated: 2025-04-24